2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide,
HC 030031,
HC-030031,
HC030031,
HC-030031,
349085-38-7,
HC 030031,
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide,
HEQDZPHDVAOBLN-UHFFFAOYSA-N,
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide,
CHEMBL1086310,
2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)-N-(4-isopropylphenyl)acetamide,
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-yl)-N-(4-isopropylphenyl)acetamide,
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-[4-(propan-2-yl)phenyl]acetamide,
HC030031,
AC1LM9D6,
Oprea1_280240,
Oprea1_427263,
GTPL4211,
SCHEMBL1064155,
TOSLAB 829227,
CTK4H3225,
DTXSID10360763,
HMS3651P10,
ZINC898145,
BCP06674,
EX-A2393,
2459AH,
BBL036191,
BDBM50318463,
MFCD02007349,
s2918,
STK096101,
AKOS001460528,
CS-1040,
MCULE-9547297783,
QC-7693,
KS-00000L88,
NCGC00378740-04,
BAS 02065857,
HY-15064,
AB0096991,
AB1009212,
FT-0669107,
H-105,
ST50720012,
SW131228-2,
HC-030031, >=98% (HPLC), powder,
W-5282,
J-019797,
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide.,
2-(1,3-dimethyl-2,6-dioxo(1,3,7-trihydropurin-7-yl))-N-[4-(methylethyl)phenyl] acetamide,
2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)-N-[4-(propan-2-yl)phenyl]acetamide,
D0D6MC,
C18H21N5O3,
ZINC00898145,
CID1150897,
B2100,
A13278,
C552888,
TRPA1 inhibitor (pain/inflammation), Hydra Biosciences/Cubist Pharmaceuticals,
1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide,